15.2
[1]. Bradner J, et al. Targeted protein degradation to attenuate adoptive t-cell therapy associated adverse inflammatory responses. WO 20170231 A1

P26-P270-P20-P302+P352-P330-P362+P36-P05-P501
GHS06,GHS0
211
![]()